• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Adv . COVID-19 in low-tolerance border quarantine systems: Impact of the Delta variant of SARS-CoV-2

tetano

Editor, Senior Moderator
Sci Adv


. 2022 Apr 8;8(14):eabm3624.
doi: 10.1126/sciadv.abm3624. Epub 2022 Apr 8.
COVID-19 in low-tolerance border quarantine systems: Impact of the Delta variant of SARS-CoV-2


Cameron Zachreson[SUP] 1 [/SUP], Freya M Shearer[SUP] 2 [/SUP], David J Price[SUP] 2 3 [/SUP], Michael J Lydeamore[SUP] 4 [/SUP], Jodie McVernon[SUP] 2 3 5 [/SUP], James McCaw[SUP] 2 3 6 [/SUP], Nicholas Geard[SUP] 1 3 [/SUP]



Affiliations

Abstract

In controlling transmission of coronavirus disease 2019 (COVID-19), the effectiveness of border quarantine strategies is a key concern for jurisdictions in which the local prevalence of disease and immunity is low. In settings like this such as China, Australia, and New Zealand, rare outbreak events can lead to escalating epidemics and trigger the imposition of large-scale lockdown policies. Here, we develop and apply an individual-based model of COVID-19 to simulate case importation from managed quarantine under various vaccination scenarios. We then use the output of the individual-based model as input to a branching process model to assess community transmission risk. For parameters corresponding to the Delta variant, our results demonstrate that vaccination effectively counteracts the pathogen's increased infectiousness. To prevent outbreaks, heightened vaccination in border quarantine systems must be combined with mass vaccination. The ultimate success of these programs will depend sensitively on the efficacy of vaccines against viral transmission.
 
Back
Top Bottom